Drug Description in Trials / DrugBank / KEGG DRUG

Search results

descriptions per page:

Showing 1 to 3 of 3 descriptions

Filter by

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	Combination Product: Ravulizumab OBDS	1件: Ravulizumab	1件: D11054 (Name: Ravulizumab)	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ...	1件: 62
2	RAVULIZUMAB	1件: Ravulizumab	1件: D11054 (Name: Ravulizumab)	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ...	7件: 2, 11, 13, 50, 62, 66, 109
3	ULTOMIRIS ™ (ravulizumab-cwvz)	1件: Ravulizumab	1件: D11054 (Name: Ravulizumab)	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ...	1件: 62

First Previous1Next Last